134 related articles for article (PubMed ID: 37170994)
1. Thiazole, Isatin and Phthalimide Derivatives Tested
Pinto AF; Nunes JS; Severino Martins JE; Leal AC; Silva CCVC; da Silva AJFS; da Cruz Olímpio DS; da Silva ETN; Campos TA; Lima Leite AC
Curr Med Chem; 2024; 31(20):2991-3032. PubMed ID: 37170994
[TBL] [Abstract][Full Text] [Related]
2. Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3/7, and EGFR tyrosine kinase activity and molecular modeling study.
Donarska B; Świtalska M; Płaziński W; Wietrzyk J; Łączkowski KZ
Bioorg Chem; 2021 May; 110():104819. PubMed ID: 33752144
[TBL] [Abstract][Full Text] [Related]
3. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
Freitas LAB; Sousa C; Lima BS; Duarte D; Gomes PATM; Ramos CGC; Costa VCM; Pitta MGDR; Rêgo MJBM; de Simone CA; Videira M; Leite ACL
Chem Biol Interact; 2024 May; 394():110954. PubMed ID: 38518852
[TBL] [Abstract][Full Text] [Related]
4. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
5. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
Pawar S; Kumar K; Gupta MK; Rawal RK
Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
[TBL] [Abstract][Full Text] [Related]
6. Isatin derivatives with activity against apoptosis-resistant cancer cells.
Evdokimov NM; Magedov IV; McBrayer D; Kornienko A
Bioorg Med Chem Lett; 2016 Mar; 26(6):1558-1560. PubMed ID: 26883150
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
Top Curr Chem (Cham); 2019 May; 377(3):15. PubMed ID: 31073777
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in isatin hybrids as potential anticancer agents.
Ding Z; Zhou M; Zeng C
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
[TBL] [Abstract][Full Text] [Related]
13. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
14. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
15. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
de Siqueira LRP; de Moraes Gomes PAT; de Lima Ferreira LP; de Melo Rêgo MJB; Leite ACL
Eur J Med Chem; 2019 May; 170():237-260. PubMed ID: 30904782
[TBL] [Abstract][Full Text] [Related]
16. Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma mansoni.
de Oliveira SA; de Oliveira Barbosa M; Filho CALM; Oliveira AR; de Sousa FA; de Farias Santiago E; de Oliveira Filho GB; de Moraes Gomes PAT; da Conceição JM; Brayner FA; Alves LC; Leite ACL
Parasitol Res; 2018 Jul; 117(7):2105-2115. PubMed ID: 29736731
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activity and mechanism of action of new phthalimido-1,3-thiazole derivatives.
Oliveira AR; Dos Santos FA; Ferreira LPL; Pitta MGDR; Silva MVO; Cardoso MVO; Pinto AF; Marchand P; de Melo Rêgo MJB; Leite ACL
Chem Biol Interact; 2021 Sep; 347():109597. PubMed ID: 34303695
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of some new phthalimide analogues.
al-Soud YA; al-Masoudi NA
Pharmazie; 2001 May; 56(5):372-5. PubMed ID: 11400551
[TBL] [Abstract][Full Text] [Related]
20. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
